Patents Assigned to Glenmark Pharmaceuticals Limited
  • Dry Powder Inhaler
    Publication number: 20190275269
    Abstract: The present invention relates to a dry powder inhaler for administering a medicament via oral inhalation route to a subject. Particularly, the dry powder inhaler according to present invention is suitable for delivering accurate doses of a medicament in different ranges of inspiratory capacity of the subject.
    Type: Application
    Filed: May 23, 2019
    Publication date: September 12, 2019
    Applicant: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Ulhas DHUPPAD, Rachel Rachel STRIEBIG, Scott Alexander LEWIS, Matthew David ALLEN, Lai Chiu TANG, Stuart Robert ABERCROMBIE, John William Sanford HALE, Thomas Stephen COLLINGS
  • Dry powder inhaler
    Patent number: 10357622
    Abstract: The present invention relates to a dry powder inhaler for administering a medicament via oral inhalation route to a subject. Particularly, the dry powder inhaler according to present invention is suitable for delivering accurate doses of a medicament in different ranges of inspiratory capacity of the subject.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: July 23, 2019
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Ulhas Dhuppad, Rachel Victoria Striebig, Scott Alexander Lewis, Matthew David Allen, Lai Chiu Tang, Stuart Robert Abercrombie, John William Sanford Hale, Thomas Stephen Collings
  • Process for preparation of ospemifene
    Patent number: 10138190
    Abstract: The present invention relates to a process for the preparation of ospemifene and pharmaceutically acceptable salts thereof which comprises the step of recycling the undesired E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: November 27, 2018
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Veerabhadra Swamy, Kumar Hari Bhushan, Shekhar Bhaskar Bhirud, Dilipkumar Jibhau Patil, Eknath Kundlik Khemnar
  • Amorphous form of lomitapide mesylate
    Patent number: 10138206
    Abstract: Provided is novel amorphous form of lomitapide mesylate salt and process for preparation thereof.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: November 27, 2018
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Samir Naik, Sushanta Mishra, Vipin Pandey, Deepak S. Patekar
  • Process for the preparation of efinaconazole
    Patent number: 10125115
    Abstract: The present invention relates to a process for the preparation of Efinaconazole and salts thereof.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: November 13, 2018
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Samir Naik, Sushanta Mishra, Abhijit Pardeshi, Sri Hari Galla, Suresh Babu Narayanan
  • Process for preparation of azelaic acid
    Patent number: 10106483
    Abstract: Provided is a process for preparing azelaic acid.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: October 23, 2018
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Kumar Hari Bhushan, Prem Chand, Amit Anant Thanedar, Amol Anant Kadam, Krishna Baban Narawade
  • Process for preparation of dimethyl fumarate
    Patent number: 9840456
    Abstract: The present invention relates to a process for the preparation of dimethyl fumarate, a compound of formula I, in a purity of at least 99.0% as determined by HPLC, containing less than 400 ppm of an anion of a mineral acid and less than 5 ppm of dimethyl maleate.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: December 12, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Kumar Hari Bhushan, H M Veerabhadra Swamy, Dilipkumar Jibhau Patil, Avikumar Digambar Dabe
  • Process for preparation of alogliptin
    Patent number: 9776985
    Abstract: Provided is a novel process for the preparation of alogliptin.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: October 3, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Navin Ganesh Bhatt, Samir Naik, Ajay Kumar Sharma, Mahendra Joma Choraghe, Shekhar Bhaskar Bhirud
  • Process for preparation of canagliflozin
    Patent number: 9695159
    Abstract: The present invention relates to a process for the preparation of canagliflozin and intermediates thereof.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: July 4, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Samir Naik, Sachin Srivastava, Dinesh Deore, Sukumar Sinha
  • Process for the preparation of tofacitinib and intermediates thereof
    Patent number: 9670160
    Abstract: The present invention relates to process for the preparation of tofacitinib and intermediates thereof.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: June 6, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Sushanta Mishra, Suresh Babu Narayanan, Sachin Bhagwan Naykodi, Abhijit Ajaysinh Pardeshi, Ashu Dhiman, Samir Naik
  • Process for the preparation of rivaroxaban
    Patent number: 9663505
    Abstract: Disclosed is a process for the preparation of rivaroxaban and purifying rivaroxaban.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: May 30, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shrikant Prabhakar Keshav, Sanjay Shashikant Bhise, Hemant Harishchandra Kamble, Ganesh Chaudhari, Deepak Subhash Patil, Srinivas Reddy Sanikommu, Kumar Hari Bhushan, Shekhar Bhaskar Bhirud
  • Process for the preparation of dipeptidylpeptidase inhibitors
    Patent number: 9593119
    Abstract: The present invention provides a process for the preparation of linagliptin, a compound of Formula I, the process comprising deprotecting a compound of Formula II wherein R1 and R2 together with the nitrogen to which they are attached form a phthalimido group, wherein the aromatic ring of the phthalimido group is substituted with one or more R3 substituents selected from the group consisting of halogen, alkyl, nitro and amino; or R1 is H and R2 is selected from the group consisting of trialkylsilyl, 2-trialkylsilylethoxycarbamates, acetyl, trihaloacetyl, 9-fluorenylmethoxycarbonyl, trityl, alkylsulfonyl, arylsulfonyl, diphenylphosphine and sulfonylethoxycarbonyl.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: March 14, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Sunil Kumar Singh, Sachin Srivastava, Shekhar Bhaskar Bhirud
  • Process for the preparation and purification of apixaban
    Patent number: 9567332
    Abstract: The present invention provides a process for the preparation and purification of apixaban.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: February 14, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Sushanta Mishra, Suresh Babu Narayanan, Sachin Bhagwan Naykodi, Samir Naik, Sachin Srivastava, Pramod Vitthal Patil
  • Process for the preparation of ivacaftor and solvates thereof
    Patent number: 9550735
    Abstract: The present invention provides process for the preparation of ivacaftor and solvates thereof.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: January 24, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Shekhar Bhaskar Bhirud, Samir Naik, Sachin Srivastava, Ramesh Santosh Badgujar, Sachin Lad, Sukumar Sinha, Mohammad Amjed Khan
  • Process for the preparation of teneligliptin
    Patent number: 9518048
    Abstract: A process for the preparation of teneligliptin.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: December 13, 2016
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Suresh Mahadev Kadam, Bipin Parsottam Kansagra, Ramchandran Vishnue Kale, Jayant Prakashrao Patil, Venkataramana Reddy Yemireddy, Shailendra Nilkanth Bhadane, Uddhav Popat Chaudhar, Ulhas Digambar Patil, Shekhar Bhaskar Bhirud
  • Process for the preparation of arformoterol or salt thereof
    Patent number: 9499475
    Abstract: Provided is an improved process for the preparation of arformoterol L-(+)-tartrate, and more specifically provided is a novel process for the preparation of arformoterol L-(+)-tartrate via arformoterol D-(?)-tartrate.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: November 22, 2016
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Shekhar Bhaskar Bhirud, Suresh Mahadev Kadam, Sachin Baban Gavhane, Shailesh Shrirang Pawase, Aniket Ashokrao Deshpande, Anil Subhash Bhujbal
  • Process for preparation of substituted 3'-hydroazino-diphenyl-3-carboxylic acid compounds
    Patent number: 9440927
    Abstract: The present invention provides a process for the preparation of substituted 3?-hydrazino-biphenyl-3-carboxylic acid compounds. The present invention further provides a process for the preparation of 3?-{N?-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo -1,5-dihydro-pyrazol-4-ylidene]hydrazino}-2?-hydroxybiphenyl-3-carboxylic acid, its intermediate compounds and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: September 13, 2016
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Bhargav Krishnaji Upadhye, Shivaji Eknath Jagadale, Mukesh Soni
  • Process for the preparation of dipeptidylpeptidase inhibitors
    Patent number: 9353114
    Abstract: Provided is a process for the preparation of linagliptin of Formula I, comprising deprotecting a compound of Formula II wherein R1 and R2 together with the nitrogen to which they are attached form a phthalimido group, wherein the aromatic ring of the phthalimido group is substituted with one or more R3 substituents selected from the group consisting of halogen, alkyi, nitro and amino; or R1 is H and R2 is selected from the group consisting of trialkylsilyl, 2-trialkylsilylethoxycarbamates, acetyl, trihaloacetyl, 9-fluorenylmethoxycarbonyl, trityl, alkylsulfonyl, arylsulfonyl, diphenylphosphine and sulfonylethoxycarbonyl.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: May 31, 2016
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Sunil Kumar Singh, Sachin Srivastava, Shekhar Bhaskar Bhirud
  • Inhaler
    Patent number: D797920
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: September 19, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Taranpreet Singh Lamba, Pradeep Patil, Rajneesh Shrivastava, Mayank Gupta, Karsten Nielsen, Neal Anderson, Ryan Hall, Saad Chaudry, Alex Garfield, Ben Clement
  • Inhaler
    Patent number: D804015
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: November 28, 2017
    Assignee: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Taranpreet Singh Lamba, Pradeep Patil, Lai Chiu Tang